BlackRock, Inc. 13D and 13G filings for Laboratory Corporation of America Holdings:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-30 2:38 pm Sale |
2023-12-31 | 13G | Laboratory Corporation of America Holdings LH |
BlackRock Inc. BLK |
10,488,875 12.400% |
-2,867,451 (-21.47%) |
Filing |
| 2023-02-10 11:28 am Unchanged |
2022-12-31 | 13G | Laboratory Corporation of America Holdings LH |
BlackRock Inc. BLK |
13,356,326 13.000% |
0 (Unchanged) |
Filing |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Laboratory Corporation of America Holdings LH |
BlackRock Inc. BLK |
13,356,326 13.000% |
0 (Unchanged) |
Filing |
| 2023-01-20 5:17 pm Purchase |
2022-12-31 | 13G | Laboratory Corporation of America Holdings LH |
BlackRock Inc. BLK |
13,356,326 13.000% |
2,057,912 (+18.21%) |
Filing |
| 2022-03-09 5:18 pm Purchase |
2022-02-28 | 13G | Laboratory Corporation of America Holdings LH |
BlackRock Inc. BLK |
11,298,414 10.400% |
1,666,999 (+17.31%) |
Filing |
| 2022-02-01 5:14 pm Purchase |
2021-12-31 | 13G | Laboratory Corporation of America Holdings LH |
BlackRock Inc. BLK |
9,631,414 8.600% |
514,309 (+5.64%) |
Filing |
| 2021-01-29 5:22 pm Sale |
2020-12-31 | 13G | Laboratory Corporation of America Holdings LH |
BlackRock Inc. BLK |
9,117,106 8.000% |
-1,190,933 (-11.55%) |
Filing |